Skip to main content

As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.

Call for Papers: Neuroinflammation in the Retina

We are proud to present a new Collection that seeks to discover novel immune mechanisms in the diseased retina to offer novel diagnostic markers or highlight targets for immuno-modulatory therapies that could help to reduce the burden of vision loss worldwide.

Read More

Call for Papers: Neuroimmune and Neuroinflammatory Mechanisms in Traumatic Brain Injury


Journal of Neuroinflammation is presenting a new Collection of articles that will explore novel functional mechanisms after a traumatic brain injury with an eye towards elucidating and modifying the pathogenic progression to the various post-traumatic syndromes.

Read More

Articles

Top 10: Most Cited Articles of 2022 and 2021

The semantics of microglia activation: neuroinflammation, homeostasis, and stress
Samuel C. Woodburn, Justin L. Bollinger and Eric S. Wohleb 

Inflammation after spinal cord injury: a review of the critical timeline of signaling cues and cellular infiltration
Daniel J. Hellenbrand, Charles M. Quinn, Zachariah J. Piper, Carolyn N. Morehouse, Jordyn A. Fixel & Amgad S. Hanna

The association of neutrophil to lymphocyte ratio, platelet to lymphocyte ratio, and lymphocyte to monocyte ratio... 
Gong, P., Liu, Y., Gong, Y. et al. 

Mer regulates microglial/macrophage M1/M2 polarization and alleviates neuroinflammation following traumatic brain injury
Wu, H., Zheng, J., Xu, S. et al. 

Edaravone ameliorates depressive and anxiety-like behaviors via Sirt1/Nrf2/HO-1/Gpx4 pathway
Dang, R., Wang, M., Li, X. et al. 

Isoliquiritin ameliorates depression by suppressing NLRP3-mediated pyroptosis via miRNA-27a/SYK/NF-κB axis
Yuanjie Li, Wen Song, Yue Tong, Xia Zhang, Jianjun Zhao, Xiaojuan Gao, Jingjiao Yong & Hanqing Wang 

Neuromyelitis optica spectrum disorders: from pathophysiology to therapeutic strategies
Edgar Carnero Contentti and Jorge Correale

Uncovering sex differences of rodent microglia
Jinming Han, Yueshan Fan, Kai Zhou, Klas Blomgren & Robert A. Harris

Sirtuin 3 protects against anesthesia/surgery-induced cognitive decline in aged mice by suppressing hippocampal neuroinflammation
Liu, Q., Sun, YM., Huang, H. et al. 

Microglia in depression: an overview of microglia in the pathogenesis and treatment of depression
Haixia Wang, Yi He, Zuoli Sun, Siyu Ren, Mingxia Liu, Gang Wang & Jian Yang

Aims and scope

Journal of Neuroinflammation is a fully open access journal that focuses on interactions of the immune system (and especially the innate immune system) with the nervous system. Read more

Editors-in-Chief

Monica J Carson, PhD, University of California, Riverside, USA
Tammy Kielian, PhD, University of Nebraska Medical Center, USA

Reasons to publish with us

  • Top-ranking journal focusing on the innate immunological response of the nervous system
  • High-quality peer review
  • High visibility for your work: freely accessible to all

JNEU Offers In Review!

Journal of Neuroinflammation, in partnership with Research Square, is now offering In Review. Authors choosing this free optional service will be able to:

  • Share their work with fellow researchers to read, comment on, and cite even before publication
  • Showcase their work to funders and others with a citable DOI while it is still under review
  • Track their manuscript - including seeing when reviewers are invited, and when reports are received 

Annual Journal Metrics

  • 2022 Citation Impact
    9.3 - 2-year Impact Factor
    9.8 - 5-year Impact Factor
    1.792 - SNIP (Source Normalized Impact per Paper)
    2.439 - SJR (SCImago Journal Rank)

    2023 Speed
    12 days submission to first editorial decision for all manuscripts (Median)
    109 days submission to accept (Median)

    2023 Usage 
    3,039,907 downloads
    5,296 Altmetric mentions